General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Here's Why Merck (MRK) is a Strong Momentum Stock | zacks.com • |
Here's Why Merck (MRK) is a Strong Momentum Stock | news.google.com • |
Here's Why Merck (MRK) is a Strong Momentum Stock | news.google.com • |
Here's Why Merck (MRK) is a Strong Momentum Stock | news.google.com • |
Biotech Stocks: The Top 5 To Watch As Shares Trend Down | news.google.com • |
Best Healthcare Stocks of May 2024 – Forbes Advisor | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-25 | 2024-03 | 1.94 | 2.07 | 0.13 | 6.70% |
2024-02-01 | 2023-12 | -0.09 | 0.03 | 0.12 | 133.33% |
2023-10-26 | 2023-09 | 1.94 | 2.13 | 0.19 | 9.79% |
2023-08-01 | 2023-06 | -2.17 | -2.06 | 0.11 | 5.07% |
2023-04-27 | 2023-03 | 1.34 | 1.4 | 0.06 | 4.48% |
2023-02-02 | 2022-12 | 1.56 | 1.62 | 0.06 | 3.85% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-05 | Truist Securities | Upgrade | Buy | Buy |
2023-10-03 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-21 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-21 | CHATTOPADHYAY SANAT | Officer | 157.19K | Stock Award(Grant) |
2024-02-13 | DAVIS ROBERT M | Chief Executive Officer | 348.33K | Sale |
2024-01-21 | DELUCA RICHARD ROBERT JR. | Officer | 137.01K | Stock Award(Grant) |
2024-02-08 | LI DEAN Y | Officer | 46.24K | Sale |
2024-02-13 | LITCHFIELD CAROLINE | Chief Financial Officer | 50.91K | Sale |
2024-02-01 | MIZELL STEVEN CRAIG | Officer | 23.62K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 243.64M | 28.11B | 9.60% |
2023-06-29 | Blackrock Inc. | 205.65M | 23.73B | 8.10% |
2023-06-29 | State Street Corporation | 118.56M | 13.68B | 4.67% |
2023-06-29 | Wellington Management Group, LLP | 77.25M | 8.91B | 3.04% |
2023-06-29 | Geode Capital Management, LLC | 52.72M | 6.08B | 2.08% |
2023-06-29 | FMR, LLC | 38.96M | 4.50B | 1.54% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 79.16M | 9.13B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 60.41M | 6.97B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 28.37M | 3.13B | 1.12% |
2023-08-30 | SPDR S&P 500 ETF Trust | 27.96M | 3.05B | 1.10% |
2023-08-30 | iShares Core S&P 500 ETF | 23.73M | 2.59B | 0.94% |
2023-06-29 | Vanguard Index-Value Index Fund | 22.05M | 2.54B | 0.87% |
Dividend | Date |
---|---|
0.77 | 2024-03-14 |
0.77 | 2023-12-14 |
0.73 | 2023-09-14 |
0.73 | 2023-06-14 |
0.73 | 2023-03-14 |
0.73 | 2023-01-09 |
Split | Date |
---|---|
1048 : 1000 | 2021-06-03 |
2 : 1 | 1999-02-17 |
3 : 1 | 1992-05-26 |
3 : 1 | 1988-05-26 |
2 : 1 | 1986-05-27 |
2 : 1 | 1972-06-01 |
This is the biggest POS manipulated media stock
$MRK cannot believe I thought this was a good Investment. Been nothing but a POS
$SRNE Has a better option
Sorrento therapeutics has better options
Merck is interested in Caribou Biosciences. Take a look $CRBU
Leader in CRISPR Gene editing. Cure to all diseases.
Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.
Market cap 1.5 Billion.
They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:
https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude
They have about $500 Million in cash from recent IPO.
Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006
Check out patents:
Working on cure for cancer.
This has potential for x 1000
New CRISPR/Cas9 patent issued to Carribou Bio recently
Do your own due diligence.
Good luck
Finally!!!
I am going to short this fluff
Be careful there are better products out there
$SRNE has a better product! What you all going to do when we get approval first !
Has it been approved